Last updated on August 2018

A Study in Adult Patients With Type I III or IV Osteogenesis Imperfecta Treated With BPS804

Brief description of study

The purpose of this study is to select a suitable dose of BPS804 by measuring the strength/quality of bone using a special type of CT scanner. Participants will be treated for 12 months and followed up for a further 12 months.

Clinical Study Identifier: NCT03118570

Contact Investigators or Research Sites near you

Start Over

Ian Hodgson, PhD

Mereo Investigator Site
Odense, Denmark
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.